In summary, Dox and PEDF disrupt key metabolic pathways essential for cancer cell survival, including glycolysis, the PPP, amino acid, and lipid metabolism, underscoring their ability to hinder cancer cell energetics, antioxidant defenses, and biosynthetic capacity. Here, SERPINF1 is linked to cancer.